methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate

C19H30N2O4 — CID 102342883

IUPACmethyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
SMILESC=CCN([C@H]1[C@H](C(=O)OC)[C@H]2C=C[C@@H]1O2)[C@H](CC)C(=O)NC(C)(C)C
InChIInChI=1S/C19H30N2O4/c1-7-11-21(12(8-2)17(22)20-19(3,4)5)16-14-10-9-13(25-14)15(16)18(23)24-6/h7,9-10,12-16H,1,8,11H2,2-6H3,(H,20,22)/t12-,13-,14+,15-,16-/m1/s1
InChIKeyFDRPUYCPGDFUSF-IBEHDNSVSA-N
MW350.46 g/mol
LogP1.66
Rot. Bonds7

About methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate

methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate (PubChem CID 102342883) has the molecular formula C19H30N2O4 and a molecular weight of 350.46 g/mol. Its IUPAC name is methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate.

Molecular Properties

Compound Namemethyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
PubChem CID102342883
Molecular FormulaC19H30N2O4
Molecular Weight350.46 g/mol
Exact Mass350.22
IUPAC Namemethyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
SMILESC=CCN([C@H]1[C@H](C(=O)OC)[C@H]2C=C[C@@H]1O2)[C@H](CC)C(=O)NC(C)(C)C
InChIInChI=1S/C19H30N2O4/c1-7-11-21(12(8-2)17(22)20-19(3,4)5)16-14-10-9-13(25-14)15(16)18(23)24-6/h7,9-10,12-16H,1,8,11H2,2-6H3,(H,20,22)/t12-,13-,14+,15-,16-/m1/s1
InChIKeyFDRPUYCPGDFUSF-IBEHDNSVSA-N
XLogP1.66
TPSA67.87 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms25
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500350.46
LogP ≤ 51.66
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

prop-2-enyl (1S,2S,3S,4R)-3-[(2-methylpropan-2-yl)oxycarbonyl-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
CID 101354364
methyl (2S,3S,3aS,7aR)-4-[(2R)-1-(tert-butylamino)-4-methyl-1-oxopentan-2-yl]-2-ethenyl-3,3a,5,7a-tetrahydro-2H-furo[3,2-b]pyridine-3-carboxylate
CID 101403537
methyl (1S,4R)-3-[[(2R)-1-(tert-butylamino)-4-methyl-1-oxopentan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
CID 134886922
methyl (1S,2S,3S,4R)-3-[(2-methylpropan-2-yl)oxycarbonyl-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
CID 138980133
ethyl (2R,3S,4S,5S)-2,5-bis(ethenyl)-4-[[(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-enoyl]amino]oxolane-3-carboxylate
CID 101381316
ethyl (1R,2S,3S,4S)-3-[[(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-enoyl]amino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
CID 101381325
3-[[(2R)-1-(tert-butylamino)-4-methyl-1-oxopentan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid
CID 101403532
3-[[(2R)-1-(cyclohexylamino)-3-methyl-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid
CID 101403535
methyl (2S,3S,3aS,7aR)-4-[(2R)-1-(cyclohexylamino)-3-methyl-1-oxobutan-2-yl]-2-ethenyl-3,3a,5,7a-tetrahydro-2H-furo[3,2-b]pyridine-3-carboxylate
CID 101403541
(2R)-N-cyclohexyl-3-methyl-2-[(1S,2S,7R,9S)-14-oxo-8,13-dioxa-3-azatricyclo[7.5.0.02,7]tetradeca-5,10-dien-3-yl]butanamide
CID 101403544
ethyl (1R,2S,3R,4S)-3-[[(2S)-1-(tert-butylamino)-3,3-dimethyl-1-oxobutan-2-yl]amino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate
CID 101424659
(1R,2S,3R,4S)-3-[[(2S)-1-(tert-butylamino)-3,3-dimethyl-1-oxobutan-2-yl]amino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid
CID 101424666

Frequently Asked Questions

What is the IUPAC name of methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate?
The IUPAC name of methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate (CID 102342883) is methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate.
What is the SMILES notation for methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate?
The canonical SMILES for methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate is C=CCN([C@H]1[C@H](C(=O)OC)[C@H]2C=C[C@@H]1O2)[C@H](CC)C(=O)NC(C)(C)C.
What is the InChIKey of methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate?
The InChIKey is FDRPUYCPGDFUSF-IBEHDNSVSA-N. The full InChI is InChI=1S/C19H30N2O4/c1-7-11-21(12(8-2)17(22)20-19(3,4)5)16-14-10-9-13(25-14)15(16)18(23)24-6/h7,9-10,12-16H,1,8,11H2,2-6H3,(H,20,22)/t12-,13-,14+,15-,16-/m1/s1.
What are the key properties of methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate?
methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate has a molecular weight of 350.46 g/mol, XLogP of 1.66, 7 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (1R,2S,3S,4S)-3-[[(2R)-1-(tert-butylamino)-1-oxobutan-2-yl]-prop-2-enylamino]-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate is sourced from PubChem (CID 102342883), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).